Delaware | 000-06920 | 94-1655526 | ||
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
3050 Bowers Avenue P.O. Box 58039 |
||
Santa Clara, CA | 95052-8039 | |
(Address of principal executive offices) |
(Zip Code) |
Item 2.02 Results of Operations and Financial Condition. | ||||||||
Item 9.01 Financial Statements and Exhibits. | ||||||||
SIGNATURES | ||||||||
EXHIBIT INDEX | ||||||||
EXHIBIT 99.1 |
Exhibit No. | Description | |
99.1
|
Press Release issued by Applied Materials, Inc. dated February 12, 2008. |
Applied Materials, Inc. (Registrant) |
||||
Date: February 12, 2008 | By: | /s/ Joseph J. Sweeney | ||
Joseph J. Sweeney | ||||
Senior Vice President, General Counsel and Corporate Secretary |
Exhibit No. | Description | |
99.1
|
Press Release issued by Applied Materials, Inc. dated February 12, 2008. |
Release:
|
Immediate | |||
Contact:
|
Randy Bane (investment community) | David Miller (editorial/media) | ||
(408) 986-7977 | (408) 563-9582 |
| Net Sales: $2.09 billion (8% decrease year over year; 12% decrease quarter over quarter) |
| Net Income: $262 million (35% decrease year over year; 38% decrease quarter over quarter) |
| EPS: $0.19 ($0.10 decrease year over year; $0.11 decrease quarter over quarter) |
| New Orders: $2.50 billion (2% decrease year over year; 13% increase quarter over quarter) |
Three Months Ended | Three Months Ended | Three Months Ended | ||||||||||||||||||||||||||||||||||
January 27, 2008 | October 28, 2007 | January 28, 2007 | ||||||||||||||||||||||||||||||||||
Operating | Operating | Operating | ||||||||||||||||||||||||||||||||||
New | Net | Income | New | Net | Income | New | Net | Income | ||||||||||||||||||||||||||||
(In millions) | Orders | Sales | (Loss) | Orders | Sales | (Loss) | Orders | Sales | (Loss) | |||||||||||||||||||||||||||
Silicon |
$ | 1,075 | $ | 1,237 | $ | 445 | $ | 1,343 | $ | 1,511 | $ | 550 | $ | 1,755 | $ | 1,490 | $ | 520 | ||||||||||||||||||
Applied Global
Services |
610 | 595 | 149 | 645 | 605 | 159 | 718 | 560 | 159 | |||||||||||||||||||||||||||
Display |
555 | 133 | 34 | 120 | 189 | 47 | 34 | 196 | 50 | |||||||||||||||||||||||||||
Energy and
Environmental
Solutions |
260 | 122 | (48 | ) | 98 | 62 | (30 | ) | 31 | 32 | (15 | ) |
Three Months Ended | ||||||||
January 27, | January 28, | |||||||
(In thousands, except per share amounts) | 2008 | 2007 | ||||||
Net sales |
$ | 2,087,397 | $ | 2,277,267 | ||||
Cost of products sold |
1,152,416 | 1,214,729 | ||||||
Gross margin |
934,981 | 1,062,538 | ||||||
Operating expenses: |
||||||||
Research, development and engineering |
273,219 | 287,567 | ||||||
Marketing and selling |
123,917 | 106,912 | ||||||
General and administrative |
115,976 | 121,811 | ||||||
Restructuring and asset impairments |
48,986 | (3,278 | ) | |||||
Income from operations |
372,883 | 549,526 | ||||||
Pre-tax loss of equity method investment |
9,586 | 3,937 | ||||||
Interest expense |
4,545 | 10,468 | ||||||
Interest income |
30,570 | 30,103 | ||||||
Income before income taxes |
389,322 | 565,224 | ||||||
Provision for income taxes |
126,946 | 161,748 | ||||||
Net income |
$ | 262,376 | $ | 403,476 | ||||
Earnings per share: |
||||||||
Basic |
$ | 0.19 | $ | 0.29 | ||||
Diluted |
$ | 0.19 | $ | 0.29 | ||||
Weighted average number of shares: |
||||||||
Basic |
1,371,245 | 1,394,710 | ||||||
Diluted |
1,383,886 | 1,409,014 | ||||||
January 27, | October 28, | |||||||
(In thousands) | 2008 | 2007 | ||||||
ASSETS |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | 1,215,649 | $ | 1,202,722 | ||||
Short-term investments |
689,907 | 1,166,857 | ||||||
Accounts receivable, net |
2,014,501 | 2,049,427 | ||||||
Inventories |
1,387,512 | 1,313,237 | ||||||
Deferred income taxes |
409,773 | 424,502 | ||||||
Other current assets |
474,464 | 448,879 | ||||||
Total current assets |
6,191,806 | 6,605,624 | ||||||
Long-term investments |
1,457,825 | 1,362,425 | ||||||
Property, plant and equipment |
2,815,860 | 2,782,204 | ||||||
Less: accumulated depreciation and amortization |
(1,750,773 | ) | (1,730,962 | ) | ||||
Net property, plant and equipment |
1,065,087 | 1,051,242 | ||||||
Goodwill, net |
1,017,705 | 1,000,176 | ||||||
Purchased technology and other intangible assets, net |
354,450 | 373,178 | ||||||
Equity method investment |
105,474 | 115,060 | ||||||
Deferred income taxes and other assets |
160,141 | 146,370 | ||||||
Total assets |
$ | 10,352,488 | $ | 10,654,075 | ||||
LIABILITIES AND STOCKHOLDERS EQUITY |
||||||||
Current liabilities: |
||||||||
Current portion of long-term debt |
$ | 2,674 | $ | 2,561 | ||||
Accounts payable and accrued expenses |
2,174,683 | 2,213,313 | ||||||
Income taxes payable |
176,113 | 157,549 | ||||||
Total current liabilities |
2,353,470 | 2,373,423 | ||||||
Long-term debt |
202,476 | 202,281 | ||||||
Other liabilities |
337,811 | 256,962 | ||||||
Total liabilities |
2,893,757 | 2,832,666 | ||||||
Stockholders equity: |
||||||||
Common stock |
13,536 | 13,857 | ||||||
Additional paid-in capital |
4,707,141 | 4,658,832 | ||||||
Retained earnings |
11,044,518 | 10,863,291 | ||||||
Treasury stock |
(8,323,728 | ) | (7,725,924 | ) | ||||
Accumulated other comprehensive income |
17,264 | 11,353 | ||||||
Total stockholders equity |
7,458,731 | 7,821,409 | ||||||
Total liabilities and stockholders equity |
$ | 10,352,488 | $ | 10,654,075 | ||||
Three Months Ended | ||||||||
January 27, | January 28, | |||||||
(In thousands) | 2008 | 2007 | ||||||
Cash flows from operating activities: |
||||||||
Net income |
$ | 262,376 | $ | 403,476 | ||||
Adjustments required to reconcile net income to cash provided by
operating activities: |
||||||||
Depreciation and amortization |
78,474 | 60,904 | ||||||
Loss on fixed asset retirements |
11,211 | 3,122 | ||||||
Restructuring and asset impairments |
48,986 | (3,278 | ) | |||||
Deferred income taxes |
3,417 | (2,457 | ) | |||||
Net recognized loss on investments |
639 | 1,767 | ||||||
Pretax loss of equity-method investment |
9,586 | 3,937 | ||||||
Equity-based compensation |
38,722 | 34,901 | ||||||
Changes in operating assets and liabilities, net of amounts acquired: |
||||||||
Accounts receivable, net |
34,926 | (24,350 | ) | |||||
Inventories |
(73,937 | ) | (110,695 | ) | ||||
Other current assets |
(22,579 | ) | (31 | ) | ||||
Other assets |
(4,984 | ) | (3,078 | ) | ||||
Accounts payable and accrued expenses |
(95,459 | ) | (107,823 | ) | ||||
Income taxes payable |
94,248 | 121,082 | ||||||
Other liabilities |
4,105 | 3,720 | ||||||
Cash provided by operating activities |
389,731 | 381,197 | ||||||
Cash flows from investing activities: |
||||||||
Capital expenditures |
(74,144 | ) | (58,901 | ) | ||||
Cash paid for acquisition, net of cash acquired |
(19,084 | ) | | |||||
Proceeds from disposition of assets held for sale |
| 9,484 | ||||||
Proceeds from sales and maturities of investments |
806,776 | 730,009 | ||||||
Purchases of investments |
(423,529 | ) | (728,520 | ) | ||||
Cash provided (used) for investing activities |
290,019 | (47,928 | ) | |||||
Cash flows from financing activities: |
||||||||
Long-term debt borrowings |
343 | | ||||||
Proceeds from common stock issuances |
15,681 | 75,094 | ||||||
Common stock repurchases |
(600,000 | ) | (132,017 | ) | ||||
Payment of dividends to stockholders |
(83,068 | ) | (69,614 | ) | ||||
Cash
provided (used) for financing activities |
(667,044 | ) | (126,537 | ) | ||||
Effect of exchange rate changes on cash and cash equivalents |
221 | 420 | ||||||
Increase in cash and cash equivalents |
12,927 | 207,152 | ||||||
Cash and cash equivalents beginning of period |
1,202,722 | 861,463 | ||||||
Cash and cash equivalents end of period |
$ | 1,215,649 | $ | 1,068,615 | ||||
Supplemental cash flow information: |
||||||||
Cash payments for income taxes |
$ | 41,878 | $ | 40,428 | ||||
Cash payments for interest |
$ | 45 | $ | 57 | ||||
Three Months Ended | ||||||||||||
January 27, | October 28, | January 28, | ||||||||||
(In thousands, except per share amounts) | 2008 | 2007 | 2007 | |||||||||
Non-GAAP Net Income |
||||||||||||
Reported net income (GAAP basis) |
$ | 262,376 | $ | 421,761 | $ | 403,476 | ||||||
Restructuring and asset impairments 1, 2, 3 |
48,986 | 3,039 | (3,278 | ) | ||||||||
Equity-based compensation expense |
38,722 | 30,889 | 34,900 | |||||||||
Certain items associated with acquisitions 4 |
31,038 | 29,497 | 13,380 | |||||||||
Costs associated with ceasing development of
beamline implant products 5 |
1,021 | 9,391 | | |||||||||
Resolution of audits of prior years income
tax filings 6 |
| | (29,863 | ) | ||||||||
Income tax effect of non-GAAP adjustments |
(37,326 | ) | (22,691 | ) | (13,434 | ) | ||||||
Non-GAAP net income |
$ | 344,817 | $ | 471,886 | $ | 405,181 | ||||||
Non-GAAP Net Income Per Diluted Share |
||||||||||||
Reported net income per diluted share
(GAAP basis) |
$ | 0.19 | $ | 0.30 | $ | 0.29 | ||||||
Restructuring and asset impairments |
0.02 | | | |||||||||
Equity-based compensation expense |
0.02 | 0.02 | 0.02 | |||||||||
Certain items associated with acquisitions |
0.02 | 0.01 | 0.01 | |||||||||
Costs associated with ceasing development
of beamline implant products |
| | | |||||||||
Resolution of audits of prior years income
tax filings |
| | (0.02 | ) | ||||||||
Non-GAAP net income per diluted share |
$ | 0.25 | $ | 0.34 | $ | 0.29 | ||||||
Shares used in diluted shares calculation |
1,383,886 | 1,403,687 | 1,409,014 | |||||||||
1 | Results for the first fiscal quarter ended January 27, 2008 included restructuring charges of $38 million associated with a global cost reduction plan. | |
2 | Results for the fiscal quarter ended January 27, 2008 and October 28, 2007 included restructuring and asset impairment charges of $11 million and $3 million, respectively, associated with ceasing development of beamline implant products. | |
3 | Results for the first fiscal quarter ended January 28, 2007 included a net benefit of $3 million from the sale of the Hillsboro, Oregon facility. | |
4 | Incremental charges attributable to acquisitions consisting of inventory fair value adjustments on products sold and amortization of purchased intangible assets. | |
5 | Results for the fiscal quarters ended January 27, 2008 and October 28, 2007 include other operating charges of $1 million and $9 million, respectively, associated with ceasing development of beamline implant products. | |
6 | Consists of benefit from the resolution of audits of prior years income tax filings. |